FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

PharMEDium Services Hydromorphone HCl 0 Recall

Hydromorphone HCl 0

PharMEDium Services, LLC. · Memphis, TN

Risk level
Class II
Reported by FDA
Nov 22, 2017
Recall ID
D-0080-2018
Check your lot numberHow we source this data

Summary

PharMEDium Services recalled Hydromorphone HCl 0 starting Oct 13, 2017. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0080-2018 on Nov 22, 2017. Reason: Superpotent drug: out of specification result for potency. Status: Terminated.

Why it was recalled

Superpotent drug: out of specification result for potency

Product description

Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40

Lot numbers, UPCs & expiration codes

Lot#: 172820134M, Exp 01/18

Where it was sold

CA, IL

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0080-2018
Classification
Class II
Status
Terminated
Recall initiated
Oct 13, 2017
FDA report date
Nov 22, 2017
Quantity
499 syringes
Recall type
Voluntary: Firm initiated
Recalling firm
PharMEDium Services, LLC.

Original FDA data

Every field from FDA enforcement report D-0080-2018, exactly as published.

Show all FDA fields
City
Memphis
State
TN
Status
Terminated
Country
United States
Event ID
78503
Address
6100 Global Dr
Code information
Lot#: 172820134M, Exp 01/18
Postal code
38141-8385
Report date
Nov 22, 2017
Product type
Drugs
Recall number
D-0080-2018
Classification
Class II
Recalling firm
PharMEDium Services, LLC.
Product quantity
499 syringes
Termination date
Jan 24, 2020
Reason for recall
Superpotent drug: out of specification result for potency
Voluntary / mandated
Voluntary: Firm initiated
Product description
Hydromorphone HCl 0.5 mg per mL in 0.9% Sodium Chloride Injection 1 mL, packaged in syringes, Rx Only , PharMEDium Services, LLC. 913 N. Davis Ave Cleveland, MS 38732, NDC 61553-352-40
Distribution pattern
CA, IL
Recall initiation date
Oct 13, 2017
Initial firm notification
Telephone
Center classification date
Nov 14, 2017

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0080-2018, published Nov 22, 2017. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls